Curis Inc (CRIS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.91M
Last updated: Nov 17, 2026 at 4:42 PM ET
Curis Inc (CRIS) Statistics
Curis (CRIS) has a market cap of $2.91M. It kept -1893.15% of revenue as net income over the last 12 months. It holds $5.01M more cash than debt, 172.26% of its market cap.
Total Valuation
| Market Cap | $2.91M |
|---|---|
| Latest price (Nov 17, 2026) | $0.54 |
Key Dates
The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.0x and 0.9x. Its year-end P/S ranged from 1.3x to 112.8x from 2016 to 2025.
| P/S Ratio | 2.0x |
|---|---|
| Forward P/S | 11.6x |
| P/B Ratio | 0.9x |
Price Statistics
The stock is down 97.96% over 52 weeks and trades 26.03% below its 50-day average.
| Beta (1Y) | 2.03 |
|---|---|
| 52-Week Change | -97.96% |
| 1-Month Change | +41.98% |
| 3-Month Change | -68.50% |
| 6-Month Change | -94.31% |
| 5-Year Change | -99.98% |
| 10-Year Change | -99.99% |
| Total Return (1Y) | -97.96% |
| Total Return (3Y CAGR) | -84.55% |
| Total Return (5Y CAGR) | -80.86% |
| Max Drawdown (1Y) | -98.62% |
| Max Drawdown (3Y) | -99.89% |
| Sharpe Ratio (1Y) | -2.58 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $0.73 |
| 200-Day Average | $7.97 |
| 52-Week Range | $0.33 to $28.40 |
| RSI (14 Days) | 44.2 |
| Average Volume (20 Days) | 12.43M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.43x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 0.43x |
|---|---|
| Quick Ratio | 0.43x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -844.53% and return on assets is -114.60% over the last 12 months.
| Return on Equity (ROE) | -844.53% |
|---|---|
| Return on Assets (ROA) | -114.60% |
| Return on Capital Employed (ROCE) | -840.77% |
| ROA (5Y Average) | -56.91% |
| Asset Turnover | 0.05x |
Scores
CRIS has an Altman Z-Score of -100.16, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -100.16 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $1.14M over the last 12 months is down 90.23% from the 12 months before.
| Revenue | $1.14M |
|---|---|
| Revenue Growth (YoY) | -90.23% |
| Gross Profit | $1.14M |
| Operating Income | -$10.59M |
| Pretax Income | -$21.54M |
| Net Income | -$21.54M |
| EBIT | -$21.45M |
| Reported EPS (TTM) | -$40.91 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 13.56% of the $18.80M in total assets.
| Cash and Equivalents | $5.01M |
|---|---|
| Total Debt | $0 |
| Net Cash | $5.01M |
| Net Cash Per Share | $1.20 |
| Working Capital | -$9.33M |
| Shareholder Equity | $2.55M |
| Book Value Per Share | $0.61 |
| Tangible Book Value | -$6.43M |
| Total Assets | $18.80M |
| Total Liabilities | $16.25M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$30.77M |
|---|---|
| FCF Per Share | -$4.61 |
| Depreciation and Amortization | $62.00K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -930.40%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -930.40% |
| Pretax Margin | -1893.15% |
| Net Margin | -1893.15% |
| EBIT Margin | -1884.71% |
Growth
Revenue fell 2.42% a year over 3 years.
| Revenue Growth (3Y CAGR) | -2.42% |
|---|---|
| Revenue Growth (5Y CAGR) | -2.71% |
Dividends and Yields
CRIS does not pay a dividend.
| Buyback Yield | -1070.23% |
|---|---|
| Shareholder Yield | -1070.23% |
Stock Splits
The last split was a 1-for-20 reverse split on Jul 6, 2026.
| Last Split Date | Jul 6, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Analyst Forecast
Consensus estimates put revenue growth at 4.61% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +4.61% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CRIS
What is CRIS's market cap?
Curis has a market cap of $2.91M.
How many shares of CRIS are outstanding?
Curis has 4.18M shares outstanding.
Does CRIS pay a dividend?
No. Curis does not pay a dividend.
How much debt does CRIS have?
Curis has $0 of total debt and $5.01M of cash and equivalents, a net cash position of $5.01M.
CRIS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors